Альтернативы менопаузальной гормональной терапии: обзор возможностей и перспектив

1. World Health Organization. World report on ageing and health. Geneva: WHO; 2015. Available at: https://apps.who.int/iris/handle/10665/186463
2. Fang Y., Liu F., Zhang X., Chen L., Liu Y., Yang L. et al. Mapping global prevalence of menopausal symptoms among middle-aged women: a systematic review and meta-analysis. BMC Public Health. 2024; 24(1): 1767. https://dx.doi.org/10.1186/s12889-024-19280-5
3. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Менопауза и климактерическое состояние у женщины. 2025. Доступно по: https://cr.minzdrav.gov.ru/view-cr/117_3
4. Baber R.J., Panay N., Fenton A. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016; 19(2): 109-50. https://dx.doi.org/10.3109/13697137.2015.1129166
5. Portman D.J., Gass M.L.S. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International society for the study of women's sexual health and the North American menopause society. Menopause. 2014; 21(10): 1063-8. https://dx.doi.org/10.1097/GME.0000000000000329
6. Сметник А.А., Иванов И.А., Ермакова Е.И., Табеева Г.И. Особенности использования менопаузальной гормональной терапии в России: результаты масштабного опроса женщин в пери- и постменопаузе. Акушерство и гинекология. 2025; 8: 196-208.
7. Burger H.G., Dudley E.C., Hopper J.L., Shelley J.M., Green A., Smith A. et al. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J. Clin. Endocrinol. Metab. 1995; 80(12): 3537-45. https://dx.doi.org/10.1210/jcem.80.12.8530596
8. Burger H.G. The endocrinology of the menopause. Maturitas. 1996; 23(2): 129-36. https://dx.doi.org/10.1016/0378-5122(95)00969-8
9. Randolph J.F. Jr., Zheng H., Sowers M.R., Crandall C., Crawford S., Gold E.B. et al. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J. Clin. Endocrinol. Metab. 2011; 96(3): 746-54. https://dx.doi.org/10.1210/jc.2010-1746
10. Magee P.J., Rowland I.R. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br. J. Nutr. 2004; 91(4): 513-31. https://dx.doi.org/10.1079/BJN20031075
11. Milligan S.R., Kalita J.C., Heyerick A., Rong H., De Cooman L., De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 1999; 84(6): 2249-52. https://dx.doi.org/10.1210/jcem.84.6.5887
12. Franco O.H., Chowdhury R., Troup J., Voortman T., Kunutsor S., Kavousi M. et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA. 2016; 315(23): 2554-63. https://dx.doi.org/10.1001/jama.2016.8012
13. Kanadys W., Barańska A., Błaszczuk A., Polz-Dacewicz M., Drop B., Kanecki K. et al. Evaluation of clinical meaningfulness of red clover (Trifolium pratense L.) extract to relieve hot flushes and menopausal symptoms in peri- and post-menopausal women: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2021; 13(4): 1258. https://dx.doi.org/10.3390/nu13041258
14. Ghazanfarpour M., Sadeghi R., Roudsari R.L., Najmabadi K.M., Bazaz M.M., Khadivzadeh T. et al. Effects of red clover on hot flash and circulating hormone concentrations in menopausal women: a systematic review and meta-analysis. Avicenna J. Phytomed. 2015; 5(6): 498-511.
15. Luís Â., Domingues F., Pereira L. Effects of red clover on perimenopausal and postmenopausal women’s blood lipid profile: a meta-analysis. Climacteric. 2018; 21(5): 446-53. https://dx.doi.org/10.1080/13697137.2018.1501673
16. Lipovac M., Chedraui P., Gruenhut C., Gocan A., Kurz C., Neuber B. et al. Effect of red clover isoflavones over skin, appendages, and mucosal status in postmenopausal women. Obstet. Gynecol. Int. 2011; 2011: 949302. https://dx.doi.org/10.1155/2011/949302
17. Gościniak A., Szulc P., Zielewicz W., Walkowiak J., Cielecka-Piontek J. Multidirectional effects of red clover (Trifolium pratense L.) in support of menopause therapy. Molecules. 2023; 28(13): 5178. https://dx.doi.org/10.3390/molecules28135178
18. Mueller M., Jungbauer A. Red clover extract: a putative source for simultaneous treatment of menopausal disorders and the metabolic syndrome. Menopause. 2008; 15(6): 1120-31. https://dx.doi.org/10.1097/gme.0b013e31817062ce
19. Mohsen A., Fatemeh K., Leila N., Mona P., Mohammad Z., Mozafar K. Pharmacological and therapeutic properties of the Red Clover (Trifolium pratense L.): an overview of the new findings. J. Tradit. Chin. Med. 2021; 41(4): 642-9. https://dx.doi.org/10.19852/j.cnki.jtcm.20210324.001
20. Якушевская О.В. Альтернативная коррекция климактерических расстройств. Медицинский совет. 2019; 13: 131-6.
21. Ших Е.В., Махова А.А., Ших Н.В., Марин Т.В., Жукова О.В. Выбор фитоэстрогенов и конструирование рациональных комбинаций с микронутриентами у пациенток в перименопаузе. Вопросы гинекологии, акушерства и перинатологии. 2023; 22(1): 83-90.
22. Lambert M.N.T., Hu L.M., Jeppesen P.B. A systematic review and meta-analysis of the effects of isoflavone formulations against estrogen-deficient bone resorption in peri- and postmenopausal women. Am. J. Clin. Nutr. 2017; 106(3): 801-11. https://dx.doi.org/10.3945/ajcn.116.151464
23. Zhuge L., Chen L., Pan W. Effects of isoflavone interventions on bone metabolism in perimenopausal and postmenopausal women: an umbrella review of meta-analyses of randomized controlled trials. Endocr. Pract. 2025; 31(2): 226-35. https://dx.doi.org/10.1016/j.eprac.2024.08.009
24. Karabin M., Hudcova T., Jelinek L., Dostalek P. Biologically active compounds from hops and prospects for their use. Compr. Rev. Food Sci. Food Saf. 2016; 15(3): 542-67. https://dx.doi.org/10.1111/1541-4337.12201
25. Dostalek P., Karabin M., Jelinek L. Hop phytochemicals and their potential role in metabolic syndrome prevention and therapy. Molecules. 2017; 22(10): 1761. https://dx.doi.org/10.3390/molecules22101761
26. Heyerick A., Vervarcke S., Depypere H., Bracke M., De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas. 2006; 54(2): 164-75. https://dx.doi.org/10.1016/j.maturitas.2005.10.005
27. Erkkola R., Vervarcke S., Vansteelandt S., Rompotti P., De Keukeleire D., Heyerick A. A randomized, double-blind, placebo-controlled, cross-over pilot study on the use of a standardized hop extract to alleviate menopausal discomforts. Phytomedicine. 2010; 17(6): 389-96. https://dx.doi.org/10.1016/j.phymed.2010.01.007
28. Aghamiri V., Mirghafourvand M., Mohammad-Alizadeh-Charandabi S., Nazemiyeh H. The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: A randomized placebo-controlled trial. Complement Ther Clin Pract. 2016; 23: 130-5. https://dx.doi.org/10.1016/j.ctcp.2015.05.001
29. Kim H.I., Kim M.K., Lee I., Yun J., Kim E.H., Seo S.K. Efficacy and safety of a standardized soy and hop extract on menopausal symptoms: a 12-week, multicenter, randomized, double-blind, placebo-controlled clinical trial. J. Altern. Complement. Med. 2021; 27(11): 959-67. https://dx.doi.org/10.1089/acm.2021.0027
30. Andreeva E., Tkeshelashvili B. Women dealing with hot flushes: the role of β-alanine. Eur. Rev. Med. Pharmacol. Sci. 2020; 24(9): 5148-54. https://dx.doi.org/10.26355/eurrev_202005_21209.
31. Roueche J.C. et al. Abufene 400 mg et bouffées de chaleur. Étude en double aveugle versus placebo. La Revue du Praticien – Médecine Générale. 1991; 5: 2385-88.
32. Евтушенко И.Д., Петров И.А., Петрова М.С., Ткачев В.Н., Кисляк С.В. Применение β-аланина для терапии дефицита эстрогенов при хирургической менопаузе. Акушерство и гинекология. 2014; 4: 93-5.
33. Зароченцева Н.В., Джиджихия Л.К. Возможности применения климала­нина при вазомоторных пароксизмах у женщин в климактерическом периоде. Российский вестник акушера-гинеколога. 2012; 12(3): 92‑7.
34. Овсянникова Т.В., Макаров И.О., Куликов И.А. Клиническая эффективность негормональных методов терапии у женщин в перименопаузе. Акушерство, гинекология и репродукция. 2013; 7(3): 26-9.
35. Nečas J., Bartosikova L., Brauner P., Kolar J. Hyaluronic acid (hyaluronan): a review. Vet. Med. 2008; 53(8): 397-411. https://dx.doi.org/10.17221/1930-VETMED
36. Nappi R.E., Martella S., Albani F., Cassani C., Martini E., Landoni F. Hyaluronic acid: a valid therapeutic option for early management of genitourinary syndrome of menopause in cancer survivors? Healthcare (Basel). 2022; 10(8): 1528. https://dx.doi.org/10.3390/healthcare10081528
37. Albalawi N.S., Almohammadi M.A., Albalawi A.R. Comparison of the efficacy of vaginal hyaluronic acid to estrogen for the treatment of vaginal atrophy in postmenopausal women: a systematic review. Cureus. 2023; 15(8): e44191. https://dx.doi.org/10.7759/cureus.44191
38. Jokar A., Davari T., Asadi N., Haghighi L., Fakouri T., Yousefi Z. Comparison of the hyaluronic acid vaginal cream and conjugated estrogen used in treatment of vaginal atrophy of menopause women: a randomized controlled clinical trial. Int. J. Community Based Nurs. Midwifery. 2016; 4(1): 69-78.
39. Agrawal S., LaPier Z., Nagpal S., Oot A., Friedman S., Hade E.M. et al. A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause. Menopause. 2024; 31(9): 750-5. https://dx.doi.org/10.1097/GME.0000000000002390
40. La Galia T., Micali A., Puzzolo D., Cancellieri F. Oral low-molecular weight hyaluronic acid in the treatment of atrophic vaginitis. Int. J. Clin. Med. 2014; 5: 617-24. https://dx.doi.org/10.4236/ijcm.2014.511084
41. Göllner I., Voss W., von Hehn U., Kammerer S. Ingestion of an oral hyaluronan solution improves skin hydration, wrinkle reduction, elasticity, and skin roughness: results of a clinical study. J. Evid. Based. Complement Altern. Med. 2017; 22(4): 816-23. https://dx.doi.org/10.1177/2156587217696061
42. Hsu T.F., Su Z.R., Hsieh Y.H., Wang M.F., Oe M., Matsuoka R., Masuda Y. Oral hyaluronan relieves wrinkles and improves dry skin: a 12-week double-blinded placebo-controlled study. Nutrients. 2021; 13(7): 2220. https://dx.doi.org/10.3390/nu13072220
43. Воскресенская М.Л., Плеханов А.Н., Мондодоев А.Г., Цыремпилов С.В. Фармакотерапевтическая эффективность календулы лекарственной. Вестник БГУ. Медицина и фармация. 2017; 1; 73-8.
44. Gharanjik F., Shojaeifard M.B., Karbalaei N., Nemati M. The effect of hydroalcoholic Calendula officinalis extract on androgen-induced polycystic ovary syndrome model in female rat. Biomed. Res. Int. 2022; 2022: 7402598. https://dx.doi.org/10.1155/2022/7402598
45. Motta A.B. Polycystic ovary syndrome and oxidative stress. Natural treatments. Curr. Med. Chem. 2025; 32(8): 1457-68. https://dx.doi.org/10.2174/0109298673270372231130071320
46. Kamali M., Sarhadynejad Z., Tajadini H., Keikha M., Salari Z., Dehesh T. et al. Evaluation of the efficacy of medicinal plants in treating bacterial vaginosis: a comprehensive systematic review of interventional studies. Iran. J. Nurs. Midwifery Res. 2024; 29(6): 649-59. https://dx.doi.org/10.4103/ijnmr.ijnmr_311_23
47. Pazhohideh Z., Mohammadi S., Bahrami N., Mojab F., Abedi P., Maraghi E. The effect of Calendula officinalis versus metronidazole on bacterial vaginosis in women: a double-blind randomized controlled trial. J. Adv. Pharm. Technol. Res. 2018; 9(1): 15-9. https://dx.doi.org/10.4103/japtr.JAPTR_305_17
48. Mandrich L., Piccolella S., Esposito A.V., Costa S., Mercadante V., Pacifico S. et al. Different extraction procedures revealed the anti-proliferation activity from vegetable semi-purified sources on breast cancer cell lines. Antioxidants (Basel). 2023; 12(6): 1242. https://dx.doi.org/10.3390/antiox12061242
49. Chalkidou A., Oikonomou E., Lambrinos D., Bothou A., Kyriakou D., Nikolettos K. et al. The comparative study of the administration of the combination preparation of isoflavones and hyaluronic acid in menopausal women for the treatment of the symptoms of menopause, urogenital atrophy and osteoporosis in relation to existing hormone replacement therapies. Mater. Sociomed. 2023; 35(3): 206-14. https://dx.doi.org/10.5455/msm.2023.35.206-214

Поступила 25.11.2025

Принята в печать 01.12.2025